Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

BA Johnson, N Ait-Daoud, CL Bowden… - The Lancet, 2003 - thelancet.com
Background Topiramate, a sulphamate fructopyranose derivative, might antagonise
alcohol's rewarding effects associated with abuse liability by inhibiting mesocorticolimbic …
被引用次数：973 相关文章

Oral topiramate for treatment of alcohol dependence: A randomised controlled trial

BA Johnson, N Ait-Daoud, CL Bowden… - The Lancet, 2003 - elibrary.ru
We recorded no serious adverse events. The following adverse events were reported more
frequently in the topiramate group than in the placebo group: dizziness (28 [middot] 0% vs …
[PDF] academia.edu

[PDF][PDF] Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

BA Johnson, N Ait-Daoud, CL Bowden… - THE LANCET, 2003 - academia.edu
Background Topiramate, a sulphamate fructopyranose derivative, might antagonise
alcohol's rewarding effects associated with abuse liability by inhibiting mesocorticolimbic …

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

BA Johnson, N Ait-Daoud, CL Bowden… - The Lancet, 2003 - Elsevier
BACKGROUND: Topiramate, a sulphamate fructopyranose derivative, might antagonise
alcohol's rewarding effects associated with abuse liability by inhibiting mesocorticolimbic …

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.

BA Johnson, N Ait-Daoud, CL Bowden… - Lancet (London …, 2003 - europepmc.org
Background Topiramate, a sulphamate fructopyranose derivative, might antagonise
alcohol's rewarding effects associated with abuse liability by inhibiting mesocorticolimbic …

Oral topiramate for treatment of alcohol dependence: A randomised controlled trial

BA Johnson, N Ait-Daoud, CL Bowden… - Lancet, 2003 - scholars.uthscsa.edu
Background: Topiramate, a sulphamate fructopyranose derivative, might antagonise
alcohol's rewarding effects associated with abuse liability by inhibiting mesocorticolimbic …

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

BA Johnson, N Ait-Daoud… - Lancet (London …, 2003 - pubmed.ncbi.nlm.nih.gov
Background Topiramate, a sulphamate fructopyranose derivative, might antagonise
alcohol's rewarding effects associated with abuse liability by inhibiting mesocorticolimbic …

Oral topiramate for treatment of alcohol dependence: A randomised controlled trial.

BA Johnson, N Ait-Daoud, CL Bowden… - The …, 2003 - psycnet.apa.org
Background: Topiramate, a sulphamate fructopyranose derivative, might antagonise
alcohol's rewarding effects associated with abuse liability by inhibiting mesocorticolimbic …

[引用][C] Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

BA Johnson, N Ait-Daoud, CL Bowden… - The Lancet, 2003 - cir.nii.ac.jp
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

BA Johnson, N Ait-Daoud, CL Bowden… - The Lancet, 2003 - thelancet.com
Background Topiramate, a sulphamate fructopyranose derivative, might antagonise
alcohol's rewarding effects associated with abuse liability by inhibiting mesocorticolimbic …